IDEAS home Printed from https://ideas.repec.org/a/vrn/commdh/y2023i1p107-113.html
   My bibliography  Save this article

Expenditures For Medicines, Paid By Nhif In Accordance With The Health Insurance Law €“ Status And Trends

Author

Listed:
  • Silvia Terezova

    (University of national and world economy – Sofia)

  • Mariya Vasileva

    (University of national and world economy – Sofia)

Abstract

The medicinal products prices regulation is one of the mechanisms for reduction the publics costs. External and internal price referencing applies. The dynamics of the public expenditures changes for the medicinal products included in the PDL was assessed by month of 2022. Based on the grouping of the annual expenditures by diseases, their structure was evaluated in order to determine the costliest diseases – rare diseases. The impact of changes in the reference value of medicinal products for the treatment of two rare diseases on the NHIF costs was evaluated, by grouping them by INN with the most significant reduction of the reference value during the considered period.

Suggested Citation

  • Silvia Terezova & Mariya Vasileva, 2023. "Expenditures For Medicines, Paid By Nhif In Accordance With The Health Insurance Law €“ Status And Trends," Conferences of the department "Economics and Management of Trade", Publishing house "Science and Economics" Varna, issue 1, pages 107-113.
  • Handle: RePEc:vrn:commdh:y:2023:i:1:p:107-113
    as

    Download full text from publisher

    File URL: https://drive.google.com/file/d/1mcMPIA7CRjE4kT8lCItgyJXFMb9gSHJ0/view?usp=sharing
    Download Restriction: no
    ---><---

    More about this item

    Keywords

    International non-patent name (INN); National Health Insurance Fund (NHIF); reimbursement value; Positive Drug List (PDL);
    All these keywords.

    JEL classification:

    • H51 - Public Economics - - National Government Expenditures and Related Policies - - - Government Expenditures and Health

    Statistics

    Access and download statistics

    Corrections

    All material on this site has been provided by the respective publishers and authors. You can help correct errors and omissions. When requesting a correction, please mention this item's handle: RePEc:vrn:commdh:y:2023:i:1:p:107-113. See general information about how to correct material in RePEc.

    If you have authored this item and are not yet registered with RePEc, we encourage you to do it here. This allows to link your profile to this item. It also allows you to accept potential citations to this item that we are uncertain about.

    We have no bibliographic references for this item. You can help adding them by using this form .

    If you know of missing items citing this one, you can help us creating those links by adding the relevant references in the same way as above, for each refering item. If you are a registered author of this item, you may also want to check the "citations" tab in your RePEc Author Service profile, as there may be some citations waiting for confirmation.

    For technical questions regarding this item, or to correct its authors, title, abstract, bibliographic or download information, contact: Michal Stojanov (email available below). General contact details of provider: https://edirc.repec.org/data/uevarbg.html .

    Please note that corrections may take a couple of weeks to filter through the various RePEc services.

    IDEAS is a RePEc service. RePEc uses bibliographic data supplied by the respective publishers.